| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745972 | Parkinsonism & Related Disorders | 2013 | 7 Pages |
Abstract
Safinamide and amantadine reduced LID in this primate model while only safinamide increased the duration of the antiparkinsonian response of l-DOPA, suggesting that safinamide may have effects on LID that are pharmacologically distinct from amantadine, which is in current clinical use for control of LID.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Laurent Grégoire, Vincent A. Jourdain, Matthew Townsend, Arthur Roach, Thérèse Di Paolo,